Miolisodol en es it fr

Miolisodol Brand names, Miolisodol Analogs

Miolisodol Brand Names Mixture

  • No information avaliable

Miolisodol Chemical_Formula


Miolisodol RX_link


Miolisodol fda sheet

Miolisodol msds (material safety sheet)

Miolisodol Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Miolisodol Molecular Weight

260.33 g/mol

Miolisodol Melting Point

92-93 oC

Miolisodol H2O Solubility

0.3 mg/ml

Miolisodol State


Miolisodol LogP


Miolisodol Dosage Forms


Miolisodol Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Miolisodol Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Miolisodol Absorption

No information avaliable

Miolisodol side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Miolisodol Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Miolisodol Organisms Affected

Humans and other mammals